{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:29:14Z","timestamp":1790036954158,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.transci.2021.103318","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T02:03:30Z","timestamp":1636682610000},"page":"103318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparative evaluation of ADVIA Centaur\u00ae XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6789-1982","authenticated-orcid":false,"given":"Priyadarsini Jayachandran","family":"Arcot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-0004","authenticated-orcid":false,"given":"Hem Chandra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Coshic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6541-1896","authenticated-orcid":false,"given":"Satendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourit","family":"Chakroborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103318_bib0005","unstructured":"National estimation of blood requirement in India \u2013 NACO. Available at: http:\/\/naco.gov.in\/sites\/default\/files\/Final%20Estimation%20Report%20of%20Blood%20Requirement%20in%20India%20%281%29.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0010","unstructured":"The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Schedule F. Part XIIB; p.268-288. Ministry of Health and Family Welfare. Department of Health. Government of India. Available at: http:\/\/www.cdsco.nic.in\/Drugs&CosmeticAct.pdf. Last accessed on November 10th 2020."},{"issue":"February (2)","key":"10.1016\/j.transci.2021.103318_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/2047-783X-15-2-66","article-title":"Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis","volume":"15","author":"Mo","year":"2010","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.transci.2021.103318_bib0020","first-page":"1","article-title":"Evaluation of assay methods and false positive results in the laboratory diagnosis of hepatitis C virus infection","volume":"2","author":"Kesli","year":"2011","journal-title":"Arch Clin Microbiol"},{"issue":"January-June (1)","key":"10.1016\/j.transci.2021.103318_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0973-6247.200777","article-title":"Chemiluminescence brings renaissance in TTI screening: primi experentia","volume":"11","author":"Rout","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2021.103318_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091150","article-title":"Mutation profiling of the Hepatitis B virus strains circulating in North Indian population","volume":"9","author":"Tuteja","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2021.103318_bib0035","unstructured":"HBsAg Qualitative, ARCHITECT HBsAg Qualitative assay, Abbott Laboratories, USA. Available at: https:\/\/www.ilexmedical.com\/files\/PDF\/HBsAgQul_ARC.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0040","unstructured":"Anti-HCV, ARCHITECT System, Abbott Laboratories, USA. Available at: https:\/\/www.ilexmedical.com\/files\/PDF\/AntiHCV_ARC.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0045","unstructured":"HIV Ag\/Ab Combo, ARCHITECT System, Abbott Laboratories, USA. Available at: https:\/\/www.ilexmedical.com\/files\/PDF\/HIVAgAbCombo.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0050","unstructured":"Syphilis T.P., ARCHITECT System, Abbott Laboratories, USA. Available at: https:\/\/www.ilexmedical.com\/files\/PDF\/Syphilis_ARC.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0055","unstructured":"HBsAgII (HBsII) - FDA. Assay for the detection of Hepatitis B Surface Antigen, ADVIA Centaur XP, XPT Immunoassay systems, SIEMENS Healthineers, Germany. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110041c.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0060","unstructured":"HCV (aHCV) - FDA. Assay for the detection of Immunoglobulin G (IgG) Antibodies to Hepatitis C virus, ADVIA Centaur XP, XPT Immunoassay systems, SIEMENS Healthineers, Germany. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf3\/P030056b.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0065","unstructured":"HIV Ag\/Ab Combo (CHIV) \u2013 FDA. Assay for the detection of HIV p24 Antigen and Antibodies to Human Immunodefeciency Virus Type 1, Including Group O (HIV-1 + \u201cO\u201d) and\/or Type 2 (HIV-2), ADVIA Centaur XP, XPT Immunoassay systems, SIEMENS Healthineers, Germany. Available at: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert---ADVIA-Centaur-HIV-Ag-Ab-Combo-%28CHIV%29-Assay.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0070","unstructured":"Syphilis (SYPH), ADVIA Centaur X.P., XPT Immunoassay systems, SIEMENS Healthineers, Germany. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/K112343.pdf. Last accessed on November 10th 2020."},{"key":"10.1016\/j.transci.2021.103318_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172101","article-title":"Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population","volume":"12","author":"Gencay","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2021.103318_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2004.10.008","article-title":"Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact","volume":"32","author":"Weber","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.transci.2021.103318_bib0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1743-422X-5-156","article-title":"An overview of molecular epidemiology of hepatits B virus (HBV) in India","volume":"5","author":"Datta","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.transci.2021.103318_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1423-0410.2009.01272.x","article-title":"Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes","volume":"98","author":"Scheiblauer","year":"2010","journal-title":"Vox Sang"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:12Z","timestamp":1761468852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1473050221003189"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103318","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of ADVIA Centaur\u00ae XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103318"}}